A Buyer's Checklist for Quality Intelligence: Beyond 'Does It Automate Tests?'

The default RFP asks "does it automate tests?" That question made sense when humans wrote legible code and a test suite was a reasonable proxy for system behavior. Two numbers should reset your scope. Roughly 41% of codebases are now AI-generated, and around 45% of AI coding tasks introduce a critical flaw or security issue. The volume of change and its defect rate moved in the same direction at the same time, and the cost of poor software quality sits near $2.41 trillion. A tool that executes scripts faster does not touch that problem. It executes a stale opinion of your system faster.

For a fintech QA lead, the buying question is different: *can this platform tell me whether a specific change is safe to release into my specific system, prove it, and let me govern who authorizes what?* That is quality intelligence, not test automation. Everything below is how you tell the two apart in an evaluation. Print it, score each vendor, and weight the ones that map to your real exposure.

The first and most disqualifying gap. Most tools evaluate the average health of your system: aggregate pass rate, total coverage, a green pipeline. None of that answers the only question that matters at release time, which is what *this diff* reaches.

Ask each vendor to demonstrate, not assert:

If a vendor can only tell you the suite is green, you have bought a faster way to be change-blind.

This is where most "AI testing" pitches quietly fail an enterprise. Autonomy without governance is a liability, especially in a regulated shop. The principle to evaluate against is agents propose, humans authorize. An agent that both writes a fix and applies it has merged the maker and the checker, collapsing exactly the separation of duties your auditors expect.

Score the governance surface on:

This is the role Governance plays in Zof's model, and it is the difference between governed autonomy and a robot with commit access.

For fintech, the deciding question usually comes six weeks later, from someone who wasn't in the room: *why did this change go live?* If the honest answer is "the build was green and it felt fine," that does not survive an incident review, an enterprise customer's security questionnaire, or a regulator.

Evaluate whether the platform produces evidence as a byproduct of how it runs, not as a separate logging project:

If evidence is a report you assemble after the fact, you don't have evidence. You have a reconstruction project waiting to happen.

Finding defects is the easy half. The hard, critical part is what happens next, and it is where you should be most skeptical of vendor claims. Unsupervised autonomous fixing is reckless; the governance around the fix is the actual engineering.

Look for a genuinely closed loop, scored end to end:

This is the Understand → Test → Reproduce → Remediate → Verify loop, executed by coordinated Testing Fleets rather than static scripts that leave no defensible record. A tool that stops at "we found 200 issues" has handed you a backlog, not a loop.

Fintech rarely lets a vendor exfiltrate production data or run change machinery in someone else's cloud. The wrong resolution is to weaken governance to fit a deployment model. The right one is to run the agents inside your perimeter while keeping the full authority and evidence model intact.

The questions that separate serious vendors:

If residency and governance are presented as a tradeoff, the architecture is wrong. They shouldn't be.

Weight these five against your real exposure rather than treating them as equal checkboxes. A practical scoring move: ask every vendor to run the same scenario on one high-stakes path, say a change to a settlement or checkout flow, and score what they actually produce.

Pick one path, define what "ready" means for it in concrete terms, and make the vendors prove it there. If you want to compare this against extending what you already own, build vs. buy and the financial-services solution are the right next reads.